![Photo from Envato](/s3/files/styles/article_details_tablet_image/public/2025-02/kidney-disease-chronic-kidney-disease-ckd-doctor-2023-11-27-05-07-46-utc-min.jpg.webp?itok=K1l5P-qd)
7MM kidney transplant rejection market to see 4.9% CAGR growth until 2034
Thanks to new therapies and the rising number of kidney transplants.
The kidney transplant rejection market across seven major markets (7MM) is projected to experience a 4.9% compound annual growth rate until 2034, said DelveInsight.
The sector’s expansion is attributed to the introduction of new therapies and the rising number of kidney transplants.
“Managing kidney transplant rejection remains a major challenge in post-transplant care, necessitating effective immunosuppressive therapies to prevent rejection and ensure long-term graft survival,” the report said.
Moreover, the increasing prevalence of end-stage renal disease further drives the market's growth.
7MM = US, Germany, France, Italy, Spain, UK, and Japan